shopping cart Your cart is empty
  • Home
  • Food
  • Glucosamine Market Analysis By Application (Nutritional Supplement, Food And Beverages & Dairy Product) , Industry Size, Growth, S...

Glucosamine Market Analysis By Application (Nutritional Supplement, Food And Beverages & Dairy Product) , Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jan 28, 2016

Key findings

 

The global glucosamine market is expected to grow at the CAGR of 14.3% during 2015-2022 and it estimated to be $1.2 billion by 2022. The global glucosamine market is majorly driven by significant growth in geriatric population, hug adoption of glucosamine products in emerging economies, global rise in adoption of food and beverages, huge consumption of glucosamine due to rise in arthritis and joint pain diseases. However, among various industrial applications healthcare is growing at the highest CAGR of XX% during 2015-2022. The most common reasons why companies are pursuing glucosamine product, are prototyping, product development and innovation.

Innovations in the glucosamine products and FDA approvals are expected to boost the market growth in coming years. Emerging economies such as India, China, Japan and Korea are expected to contribute significantly in the next few years. Moreover, increasing arthritis globally, is driving the demand of global glucosamine market.

The global glucosamine companies such as Alcan chemical division, Alfa chem, Cargill Inc, ethical naturals are constantly focusing on reducing the cost of the products and adding value to the products. Also, with increasing competition in the market companies are focusing on customized products.

 

Market segment insight

 

The application market for global glucosamine market is segmented as follows: Nutritional supplement, food and beverage and dairy product market. Nutritional supplement is further classified on the basis of glucosamine demand in nutritional supplement. Currently, the market is dominated by nutritional industry. Technological advancement and innovation enables to scale up the manufacturing process and also enables faster product development. Glucosamine application in healthcare is expected to grow at the highest CAGR XX% over the forecasted period. The growing number of incidence and prevalence rate of arthritis is expected to create significant scope for global glucosamine market.

 

Regional insight

 

Globally, North America dominates the global glucosamine market with high investments from manufacturers due to growing demand. However, Europe and APAC together covers almost 50% of the market share. Both the regions are expected to create significant opportunities for the growth of the market during the forecasted years. Growing demand for glucosamine products and rise in arthritis patients globally are the major drivers.

 

Competitive insight

 

The key players in the global glucosamine market include as Alcan chemical division, Alfa chem, Cargill Inc, ethical naturals. Other companies profiled in the report include, Dee pharmaceuticals, golden-shell biochemical co. ltd, Koyo chemical company ltd, Nutramax, Navamedic, Nutrilite and so on. Research and development is the key strategy adopted in the global glucosamine market. Also, companies are looking forward to merger and acquisition and partnerships to explore the global glucosamine market.

 

Reasons for buying the report

 

  • This report provides a detailed study of current trends in the global glucosamine industry, key growth drivers, and restraints.
  • It provides market forecast for the next 7 years (2015-2022) assessed on the basis of market growth.
  • The report also includes analysis of recent technological developments in the global glucosamine market, analysis of key market players and the key winning strategy adopted and predictive analysis.
  • The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
  • The report tracks and analyse the changing market dynamics.
  • The report also talks about emerging opportunities in the market and the future impact of major drivers and restraints of the market.
  • The report also provides extensive analysis with respect to key product segments.
  • The analysis in the report will help in making effective business decisions.
  • It provides analysis through distinctive graphs and charts and analyses strengths, weakness, opportunities and threats of major market players.

1. METHODOLOGY & SCOPE 10
    1.1. RESEARCH METHODOLOGY 10
    1.2. RESEARCH SCOPE & ASSUMPTIONS 10
    1.3. LIST OF DATA SOURCES 10

 

2. EXECUTIVE SUMMARY 10
    2.1. GLOBAL GLUCOSAMINE– INDUSTRY SUMMARY & KEY BUYING CRITERIA 10
    2.2. GLOBAL GLUCOSAMINE INDUSTRY OUTLOOK 10

 

3. MARKET SEGMENTATION 10
    3.1. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 10
    3.2. GLOBAL GLUCOSAMINE INDUSTRY VALUE CHAIN ANALYSIS 10
    3.3. VENDOR LANDSCAPE 10

 

4. GLOBAL GLUCOSAMINE MARKET DYNAMICS 10
    4.1. MARKET DRIVER ANALYSIS 10
        4.1.1. SIGNIFICANT GROWTH IN GARIATRIC POPULATION 10
    4.1.2. SIGNIFICANT GROWTH AND ADOPTION OF GLUCOSAMINE IN EMERGING ECONOMIES 10
        4.1.3. GLOBAL INCREASE AND ADOPTION OF FOOD AND BEVERAGES ARE EXPECTED TO CREATE HUGE SCOPE FOR GLOBAL GLUCOSAMINE MARKET 10
        4.1.4. RISE IN INCIDENCE AND PREVALENCE OF ARTHRITIS AND OTHER JOINT PAIN DISEASES 10
          4.1.5. GLOBAL INCREASE IN VEGAN POPULATION IS EXPECTED TO DRIVE THE MARKET 10
    4.2. MARKET RESTRAINT ANALYSIS 11
        4.2.1. HIGH COST OF THE GLUCOSAMINE PRODUCTS 11
        4.2.2. LESS CONSUMPTION IN EMERGING ECONOMIES 11
    4.3. KEY OPPORTUNITIES 11
        4.3.1. GROWING DEMAND IN UNTAPPED EMERGING ECONOMIES 11
        4.3.2. RISING AGING POPULATION 11

 

5. INDUSTRY ANALYSIS – PORTER’S 11
    5.1. GLOBAL GLUCOSAMINE INDUSTRY– PESTEL ANALYSIS 11

 

6. GLOBAL GLUCOSAMINO MARKET BY APPLICATION 2012-2022 ($ BILLION) 11
    6.1. GLOBAL NUTRITIONAL SUPPLEMENT MARKET 2012-2022 ($ BILLION) 11
        6.1.1. GLOBAL GLUCOSAMINE DEMAND IN NUTIRTIONAL SUPPLEMENT MARKET 2012-2022 ($ BILLION) 11
     6.2. GLOBAL FOOD AND BEVERAGES MARKET 2012-2022 ($ BILLION) 11
        6.2.1. GLOBAL GLUCOSAMINE DEMAND IN FOOD AND BEVERAGES MARKET 2012-2022 ($ BILLION) 11
    6.3. GLOBAL DAIRY PRODUCT MARKET 2012-2022 11
    6.3.1. GLOBAL GLUCOSAMINE DEMAND IN DAIRY PRODUCT MARKET 2012-2022 ($ BILLION) 11

 

7. GLOBAL GLUCOSAMINO INDUSTRY, REGIONAL OUTLOOK 2012-2022 ($ BILLION) 11
    7.1. GLOBAL GLUCOSAMINO MARKET SHARE BY REGION 2012-2022 ($ BILLION) 11
    7.2. NORTH AMERICA 11
        7.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 11
       7.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012–2022 ($ BILLION) 11
       7.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 11
           7.2.3.1. US 12
               7.2.3.1.1. US MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 12
           7.2.3.1.2. US MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 12
           7.2.3.2. CANADA 12
               7.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 12
              7.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 12
          7.2.3.3. MEXICO 12
              7.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 12
            7.2.3.3.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 12
    7.3. EUROPE 12
        7.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 12
       7.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012–2022 ($ BILLION) 12
    7.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 12
           7.3.3.1. GERMANY 12
               7.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 12
             7.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 12
          7.3.3.2. UK 12
              7.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 12
         7.3.3.2.2. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 12
         7.3.3.3. RUSSIA 13
             7.3.3.3.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 13
           7.3.3.3.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 13
    7.4. ASIA PACIFIC 13
        7.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 13
    7.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012–2022 ($ BILLION) 13
      7.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 13
          7.4.3.1. CHINA 13
              7.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 13
            7.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 13
         7.4.3.2. INDIA 13
            7.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 13
          7.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 13
        7.4.3.3. SOUTH KOREA 13
           7.4.3.3.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 13
        7.4.3.3.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 13
    7.5. MIDDLE EAST & AFRICA 14
        7.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 14
        7.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 14
    7.6. CENTRAL & SOUTH AMERICA 14
        7.6.1. CENTRAL & SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 14
        7.6.2. CENTRAL & SOUTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATIO 2012–2022 ($ BILLION) 14
            7.6.2.1. BRAZIL 14
                7.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 14
                7.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012–2022 ($ BILLION) 14

 

8. COMPETITIVE LANDSCAPE 15
    8.1. ALCAN CHEMICAL DIVISION 15
        8.1.1. COMPANY OVERVIEW 15
        8.1.2. FINANCIAL PERFORMANCE 15
        8.1.3. PRODUCT BENCHMARKING 15
        8.1.4. STRATEGIC INITIATIVES 15
    8.2. ALFA CHEM 15
        8.2.1. COMPANY OVERVIEW 15
        8.2.2. FINANCIAL PERFORMANCE 15
        8.2.3. PRODUCT BENCHMARKING 15
        8.2.4. STRATEGIC INITIATIVES 15
    8.3. CARGILL INC 15
        8.3.1. COMPANY OVERVIEW 15
        8.3.2. FINANCIAL PERFORMANCE 15
        8.3.3. PRODUCT BENCHMARKING 15
        8.3.4. STRATEGIC INITIATIVES 15
    8.4. DALIAN LIJIAN BIO-TECHNOLOGY DEVELOPMENT CO. LTD 15
        8.4.1. COMPANY OVERVIEW 15
        8.4.2. FINANCIAL PERFORMANCE 15
        8.4.3. PRODUCT BENCHMARKING 15
        8.4.4. STRATEGIC INITIATIVES 15
    8.5. DEE PHARMACEUTICALS LTD 15
        8.5.1. COMPANY OVERVIEW 15
        8.5.2. FINANCIAL PERFORMANCE 15
        8.5.3. PRODUCT BENCHMARKING 15
        8.5.4. STRATEGIC INITIATIVES 15
    8.6. ETHICAL NATURALS INC 15
        8.6.1. COMPANY OVERVIEW 15
        8.6.2. FINANCIAL PERFORMANCE 15
        8.6.3. PRODUCT BENCHMARKING 15
        8.6.4. STRATEGIC INITIATIVES 15
    8.7. FABRICHEM INC 15
        8.7.1. COMPANY OVERVIEW 15
        8.7.2. FINANCIAL PERFORMANCE 15
        8.7.3. PRODUCT BENCHMARKING 15
        8.7.4. STRATEGIC INITIATIVES 15
    8.8. GOLDEN-SHELL BIOCHEMICAL CO. LTD 16
        8.8.1. COMPANY OVERVIEW 16
        8.8.2. FINANCIAL PERFORMANCE 16
        8.8.3. PRODUCT BENCHMARKING 16
        8.8.4. STRATEGIC INITIATIVES 16
    8.9. KOYO CHEMICAL COMPANY LIMITED 16
        8.9.1. COMPANY OVERVIEW 16
        8.9.2. FINANCIAL PERFORMANCE 16
        8.9.3. PRODUCT BENCHMARKING 16
        8.9.4. STRATEGIC INITIATIVES 16
    8.10. NUTRAMAX LABORATORIES INC 16
        8.10.1. COMPANY OVERVIEW 16
        8.10.2. FINANCIAL PERFORMANCE 16
        8.10.3. PRODUCT BENCHMARKING 16
        8.10.4. STRATEGIC INITIATIVES 16
    8.11. NAVAMEDIC ASA 16
        8.11.1. COMPANY OVERVIEW 16
        8.11.2. FINANCIAL PERFORMANCE 16
        8.11.3. PRODUCT BENCHMARKING 16
        8.11.4. STRATEGIC INITIATIVES 16
    8.12. NUTRILITE 16
        8.12.1. COMPANY OVERVIEW 16
        8.12.2. FINANCIAL PERFORMANCE 16
        8.12.3. PRODUCT BENCHMARKING 16
        8.12.4. STRATEGIC INITIATIVES 16
    8.13. PROMAX NUTRITION CORP 16
        8.13.1. COMPANY OVERVIEW 16
        8.13.2. FINANCIAL PERFORMANCE 16
        8.13.3. PRODUCT BENCHMARKING 16
        8.13.4. STRATEGIC INITIATIVES 16
    8.14. SIMPLY SUPPLEMENTS 16
        8.14.1. COMPANY OVERVIEW 16
        8.14.2. FINANCIAL PERFORMANCE 16
        8.14.3. PRODUCT BENCHMARKING 16
        8.14.4. STRATEGIC INITIATIVES 16
    8.15. SCHIFF NUTRITION INTERNATIONAL INC 16
        8.15.1. COMPANY OVERVIEW 17
        8.15.2. FINANCIAL PERFORMANCE 17
        8.15.3. PRODUCT BENCHMARKING 17
        8.15.4. STRATEGIC INITIATIVES 17
    8.16. SYNASIA INC 17
        8.16.1. COMPANY OVERVIEW 17
        8.16.2. FINANCIAL PERFORMANCE 17
        8.16.3. PRODUCT BENCHMARKING 17
    8.17. TRIARCO INDUSTRIES INC 17
        8.17.1. COMPANY OVERVIEW 17
        8.17.2. FINANCIAL PERFORMANCE 17
        8.17.3. PRODUCT BENCHMARKING 17
    8.18. XIAMEN BLUE BAY SCIENCE & TECHNOLOGY CO. LTD 17
        8.18.1. COMPANY OVERVIEW 17
        8.18.2. FINANCIAL PERFORMANCE 17
        8.18.3. PRODUCT BENCHMARKING 17
        8.18.4. STRATEGIC INITIATIVES 17
    8.19. NESTLE INC 17
        8.19.1. COMPANY OVERVIEW 17
        8.19.2. FINANCIAL PERFORMANCE 17
        8.19.3. PRODUCT BENCHMARKING 17
        8.19.4. STRATEGIC INITIATIVES 17

TABLE # 1 GLOBAL NUTRITIONAL SUPPLEMENT MARKET 2012-2022 ($ BILLION) 17
TABLE # 2 GLOBAL GLUCOSAMINE DEMAND IN NUTIRTIONAL SUPPLEMENT MARKET 2012-2022 ($ BILLION) 17
TABLE # 3 GLOBAL FOOD AND BEVERAGES MARKET 2012-2022 ($ BILLION) 17
TABLE # 4 GLOBAL GLUCOSAMINE DEMAND IN FOOD AND BEVERAGES MARKET 2012-2022 ($ BILLION) 17
TABLE # 5 GLOBAL DAIRY PRODUCT MARKET, 2012 & 2022 17
TABLE # 6 GLOBAL GLUCOSAMINE DEMAND IN DAIRY PRODUCT MARKET 2012-2022 ($ BILLION) 17

FIGURE # 1 GLOBAL GLUCOSAMINE INDUSTRY MARKET SHARE 2012-2022 ($ BILLION) 18
FIGURE # 2 MARKET SHARE BY REGIONS 18
FIGURE # 3 UNITED STATES MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 4 CANADA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 5 MEXICO MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 6 UK MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 7 FRANCE MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 8 GERMANY MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 9 APAC MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 10 CHINA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 11 INDIA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 12 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 13 CENTRAL & SOUTH AMERICA MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18
FIGURE # 14 BRAZIL MARKET ESTIMATES AND FORECAST 2012–2022 ($ BILLION) 18

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)